Aurinia Pharmaceuticals (AUPH) Short Interest Ratio & Short Volume

Aurinia Pharmaceuticals logo
$15.40 -0.08 (-0.52%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$15.53 +0.13 (+0.87%)
As of 11/17/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aurinia Pharmaceuticals Short Interest Overview

As of October 30, 2026, Aurinia Pharmaceuticals (AUPH) had a short interest of 7.14 million shares sold short, representing 5.94% of the public float. This marks an 8.26% decrease in short interest since the prior report. The short interest ratio (days to cover) is 10.3, meaning it would take 10.3 days of the average trading volume of 922,061 shares to cover all short positions.

Current Short Interest
7,137,632 shares
Previous Short Interest
7,780,313 shares
Change Vs. Previous Report
-8.26%
Dollar Volume Sold Short
$118.84 million
Short Interest Ratio
10.3 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
134,000,000 shares
Short Percent of Float
5.94%
Today's Trading Volume
833,656 shares
Average Trading Volume
922,061 shares
Today's Volume Vs. Average
90%
Short Selling Aurinia Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

AUPH Short Interest Over Time

AUPH Days to Cover Over Time

AUPH Percentage of Float Shorted Over Time

Aurinia Pharmaceuticals Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20267,137,632 shares $118.84 million -8.3%5.9%10.31 $16.65
10/15/20267,780,313 shares $130.16 million -1.8%6.5%8.96 $16.73
9/30/20267,920,606 shares $128.46 million -7.7%6.6%9.38 $16.22
9/15/20268,576,505 shares $138.34 million -4.5%7.2%11.08 $16.13
8/31/20268,978,748 shares $144.65 million -6.6%7.5%8.56 $16.11
8/14/20269,615,436 shares $148.75 million +0.9%8.1%7.98 $15.47
7/31/20269,525,730 shares $141.74 million -1.9%8.0%9.44 $14.88
7/15/20269,714,642 shares $156.41 million +1.3%8.4%5.77 $16.10
6/30/20269,589,939 shares $162.74 million +3.6%8.5%3.88 $16.97
6/15/20269,252,751 shares $148.04 million +4.9%8.2%7.65 $16.00
5/29/20268,820,725 shares $135.22 million -2.3%7.8%7.88 $15.33
5/15/20269,024,992 shares $137.90 million +1.6%8.0%6.79 $15.28
4/30/20268,886,775 shares $136.77 million -2.5%7.9%8.68 $15.39
4/15/20269,112,230 shares $146.25 million -15.7%8.1%8.44 $16.05
3/31/202610,809,496 shares $160.20 million +6.4%9.4%8.76 $14.82
3/13/202610,160,577 shares $141.74 million +4.2%8.7%8.94 $13.95
2/27/20269,753,427 shares $138.21 million +3.1%8.6%10.6 $14.17
2/13/20269,464,612 shares $134.68 million +3.3%8.4%11.93 $14.23
1/30/20269,158,442 shares $133.07 million +4.9%7.9%9.66 $14.53
1/15/20268,730,059 shares $129.82 million +4.7%7.5%7.25 $14.87
12/31/20258,341,055 shares $133.04 million -0.6%7.2%9.97 $15.95
12/15/20258,393,142 shares $131.69 million -0.5%7.3%5.58 $15.69
11/28/20258,436,415 shares $136.68 million -1.0%7.3%5.02 $16.20
11/14/20258,530,321 shares $130.94 million +2.5%7.4%3.17 $15.35
10/31/20258,324,953 shares $109.64 million -0.8%7.2%6.84 $13.17
10/15/20258,390,000 shares $96.23 million -8.4%7.1%4.3 $11.47
9/30/20259,160,000 shares $101.22 million +2.0%7.7%4.3 $11.05
9/15/20258,980,000 shares $115.03 million +0.6%7.6%4.2 $12.81
8/31/20258,930,000 shares $107.07 million -1.4%7.5%4.4 $11.99
8/15/20259,060,000 shares $111.17 million -1.1%7.6%4.5 $12.27
7/31/20259,160,000 shares $84.64 million -13.8%7.9%4.7 $9.24
7/15/202510,630,000 shares $95.56 million +6.1%8.9%7 $8.99
6/30/202510,020,000 shares $84.87 million -4.8%8.4%6.9 $8.47
6/15/202510,530,000 shares $86.14 million +0.3%8.8%8.7 $8.18
5/31/202510,500,000 shares $82.53 million -3.5%8.7%8.2 $7.86
5/15/202510,880,000 shares $88.67 million -3.3%9.1%7.5 $8.15
4/30/202511,250,000 shares $92.70 million +2.8%9.3%8.2 $8.24
4/15/202510,940,000 shares $84.79 million -4.8%9.0%8 $7.75
3/31/202511,490,000 shares $92.38 million +0.4%9.4%7.8 $8.04
3/15/202511,440,000 shares $93.35 million -0.6%9.4%8.1 $8.16
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this fall.tc pixel

Watch the video to learn how this plan could affect you
2/28/202511,510,000 shares $91.50 million +15.5%9.4%7.9 $7.95
2/15/20259,970,000 shares $77.67 million +6.2%7.3%7.5 $7.79
1/31/20259,390,000 shares $74.65 million +25.5%N/A6.6 $7.95
1/15/20257,480,000 shares $57.52 million +29.2%N/A5.3 $7.69
12/31/20245,790,000 shares $51.99 million +4.7%N/A4.4 $8.98
12/15/20245,530,000 shares $51.82 million -11.1%N/A4.5 $9.37
11/30/20246,220,000 shares $55.11 million -9.6%N/A4.9 $8.86
11/15/20246,880,000 shares $55.87 million -6.3%N/A5.5 $8.12
10/31/20247,340,000 shares $52.92 million +2.1%N/A5.9 $7.21
10/15/20247,190,000 shares $51.77 million -0.7%N/A5.7 $7.20
9/30/20247,240,000 shares $53.07 million -4.5%N/A5.2 $7.33
9/15/20247,580,000 shares $53.29 million -13.0%N/A5.3 $7.03
8/31/20248,710,000 shares $59.32 million +2.7%N/A6.3 $6.81
8/15/20248,480,000 shares $47.40 million -13.8%N/A6.5 $5.59
7/31/20249,840,000 shares $57.86 million +13.1%N/A7.5 $5.88
7/15/20248,700,000 shares $49.33 million -15.7%N/A6.8 $5.67
6/30/202410,320,000 shares $58.93 million +1.4%N/A8.3 $5.71
6/15/202410,180,000 shares $57.52 million +10.5%N/A8 $5.65
5/31/20249,210,000 shares $49.92 million -20.1%N/A6.8 $5.42
5/15/202411,530,000 shares $61.22 million +12.4%N/A7.5 $5.31
4/30/202410,260,000 shares $52.22 million -9.9%8.1%5 $5.09
4/15/202411,390,000 shares $57.41 million -6.9%8.9%5.5 $5.04
3/31/202412,240,000 shares $61.32 million +14.9%9.6%5.2 $5.01
3/15/202410,650,000 shares $55.06 million -12.0%8.3%4.5 $5.17
2/29/202412,100,000 shares $69.21 million -28.2%9.5%4.9 $5.72
2/15/202416,850,000 shares $101.44 million -9.1%13.2%6.7 $6.02
1/31/202418,530,000 shares $139.72 million +13.1%N/A9.1 $7.54
1/15/202416,390,000 shares $126.86 million +5.3%N/A7.9 $7.74
12/31/202315,570,000 shares $139.97 million -4.6%N/A7.8 $8.99
12/15/202316,320,000 shares $153.24 million -4.6%N/A8.2 $9.39
11/30/202317,110,000 shares $147.83 million -0.5%N/A8.9 $8.64
11/15/202317,190,000 shares $140.27 million -0.5%N/A9.2 $8.16
10/31/202317,280,000 shares $126.84 million -0.9%N/A10 $7.34
10/15/202317,430,000 shares $131.07 million +2.4%N/A8.4 $7.52
9/30/202317,030,000 shares $132.32 million +0.1%N/A8 $7.77
9/15/202317,010,000 shares $150.37 million +21.9%N/A7.8 $8.84
8/31/202313,960,000 shares $126.62 million -16.4%N/A6.5 $9.07
8/15/202316,700,000 shares $159.99 million +5.6%N/A7.2 $9.58
7/31/202315,820,000 shares $183.20 million -5.3%N/A6.5 $11.58
7/15/202316,710,000 shares $185.82 million +6.8%N/A6.9 $11.12
6/30/202315,650,000 shares $151.49 million -1.2%N/A6.2 $9.68
6/15/202315,840,000 shares $157.29 million -5.2%N/A5.9 $9.93
5/31/202316,700,000 shares $149.63 million +7.6%N/A5.7 $8.96
5/15/202315,520,000 shares $168.86 million -7.1%N/A5 $10.88
4/30/202316,710,000 shares $187.99 million -3.1%13.1%5.5 $11.25
4/15/202317,250,000 shares $193.55 million -0.2%13.5%5.9 $11.22
3/31/202317,280,000 shares $189.39 million +5.5%N/A5.6 $10.96
3/15/202316,380,000 shares $155.61 million +9.5%N/A5.1 $9.50
2/28/202314,960,000 shares $135.99 million +18.1%N/A5.1 $9.09
2/15/202312,670,000 shares $99.33 million +14.9%N/A4.6 $7.84
Worse than socialism (Ad)

Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel

Watch Porter Stansberry's full investment broadcast now
1/31/202311,030,000 shares $99.82 million +48.9%N/A3.8 $9.05
1/15/20237,410,000 shares $67.51 million -2.0%N/A2.3 $9.11
12/30/20227,560,000 shares $32.66 million -10.0%N/A2.5 $4.32
12/15/20228,400,000 shares $38.05 million -4.6%N/A3.5 $4.53
11/30/20228,800,000 shares $45.14 million +6.2%N/A3.5 $5.13
11/15/20228,290,000 shares $42.69 million -27.7%N/A3.3 $5.15
10/31/202211,460,000 shares $93.17 million -4.0%N/A4.9 $8.13
10/15/202211,940,000 shares $87.64 million -4.5%N/A4.9 $7.34
9/30/202212,500,000 shares $94 million +4.5%N/A5.4 $7.52
9/15/202211,960,000 shares $90.66 million -4.6%N/A4.4 $7.58
8/31/202212,530,000 shares $92.22 million -6.1%N/A4.5 $7.36
8/15/202213,340,000 shares $115.12 million -2.5%N/A4.9 $8.63
7/31/202213,680,000 shares $111.90 million -1.2%N/A4.7 $8.18
7/15/202213,840,000 shares $145.18 million -3.0%N/A5.5 $10.49
6/30/202214,260,000 shares $143.31 million +48.4%11.7%5.8 $10.05
6/15/20229,610,000 shares $95.24 million -6.5%7.9%4.2 $9.91
5/31/202210,280,000 shares $115.96 million +7.5%8.3%4.8 $11.28
5/15/20229,560,000 shares $106.79 million -8.4%7.7%3.3 $11.17
4/30/202210,440,000 shares $107.43 million +3.0%8.3%3.6 $10.29
4/15/202210,140,000 shares $120.16 million +13.9%8.1%3.3 $11.85
3/31/20228,900,000 shares $110.18 million -0.1%7.2%2.7 $12.38
3/15/20228,910,000 shares $93.47 million -8.9%7.2%2.6 $10.49
2/28/20229,780,000 shares $120.29 million -10.8%7.9%2.7 $12.30
2/15/202210,960,000 shares $205.94 million +15.7%9.8%3.2 $18.79
1/31/20229,470,000 shares $157.77 million -18.2%8.7%2.5 $16.66
1/15/202211,570,000 shares $228.04 million +9.2%10.6%2.6 $19.71
12/31/202110,600,000 shares $242.42 million -7.7%9.4%2.4 $22.87
12/15/202111,480,000 shares $228.11 million +26.2%10.2%2.5 $19.87
11/30/20219,100,000 shares $171.44 million -14.7%8.1%1.9 $18.84

AUPH Short Interest - Frequently Asked Questions

Short interest is the volume of Aurinia Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 30th, investors have sold 7,137,632 shares of AUPH short. 5.94% of Aurinia Pharmaceuticals' shares are currently sold short. Learn More on Aurinia Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AUPH shares currently have a short interest ratio of 10.3. Learn More on Aurinia Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.94% of Aurinia Pharmaceuticals' floating shares are currently sold short.

Aurinia Pharmaceuticals saw a drop in short interest since the prior report. As of October 30th, there was short interest totaling 7,137,632 shares, a drop of 8.3% from the previous total of 7,780,313 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.94% of Aurinia Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Aurinia Pharmaceuticals: Arrowhead Pharmaceuticals, Inc. (8.53%), Praxis Precision Medicines, Inc. (15.54%), Cytokinetics, Incorporated (13.21%), Abivax SA Sponsored ADR (4.70%), Alkermes plc (12.25%), Rhythm Pharmaceuticals, Inc. (17.90%), Kiniksa Pharmaceuticals International, plc (11.38%), Oruka Therapeutics, Inc. (12.76%), Ionis Pharmaceuticals, Inc. (12.97%), GRAIL, Inc. (18.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling AUPH is an investing strategy that aims to generate trading profit from Aurinia Pharmaceuticals as its price is falling. AUPH shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aurinia Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AUPH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUPH, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AUPH:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:AUPH is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners